Arcadia Biosciences (RKDA) Misses Q3 EPS by 4c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.11), $0.04 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• RH (RH) Tops Q1 EPS by 12c
• BIG3 Basketball to go public via Graf Global merger at $290 million